Liver Disease Diagnostics Market Forecast To Reach $55.17 Billion By 2030: Key Growth Drivers And Industry Trends

Liver Disease Diagnostics Market Report

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Liver Disease Diagnostics Market Set To Climb From $41.84 Billion In 2026 To $55.17 Billion By 2030

The liver disease diagnostics market has experienced robust expansion in recent years. It is forecast to grow from $38.95 billion in 2025 to $41.84 billion in 2026, showing a compound annual growth rate (CAGR) of 7.4%. The market’s historical growth can be linked to the increasing prevalence of hepatitis infections, evolving alcohol consumption patterns, an early reliance on blood-based liver tests, the growing incidence of liver cirrhosis, and the expansion of hospital diagnostic infrastructure.

The liver disease diagnostics market size is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $55.17 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.2%. This anticipated growth throughout the forecast period stems from factors such as the increasing prevalence of NAFLD and NASH, heightened consciousness regarding preventive liver health, greater acceptance of sophisticated imaging methods, the broadening scope of population health screening initiatives, and elevated expenditures on diagnostic services within healthcare. Key trends expected during the forecast timeframe encompass an escalating need for prompt identification of liver conditions, a surge in the application of non-invasive diagnostic approaches, more extensive screening for fatty liver and fibrosis, the widening practice of routine liver function assessments, and an increased clinical emphasis on tracking disease advancement.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=44658605&type=smp&name=Liver%20Disease%20Diagnostics%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Liver Disease Diagnostics Market Industry Drivers: What’s Behind The Revenue Growth?

The liver disease diagnostics market is projected to grow substantially due to the increasing levels of alcohol consumption. This escalation in alcohol intake is influenced by factors such as evolving social norms, greater affordability, pervasive availability, and a rise in stress or mental health issues. Liver disease diagnostics are vital for monitoring the effects of alcohol consumption on liver health, assisting in the early identification of liver damage like fatty liver, hepatitis, or cirrhosis. For instance, data from the Bureau of Labor Statistics, a U.S. government agency, released in December 2024 indicated that in 2023, U.S. households allocated an average of $294 to alcoholic beverages consumed at home and $343 to those consumed away from home. Consequently, the rising alcohol consumption is a significant impetus for the expansion of the liver disease diagnostics market.

Liver Disease Diagnostics Market Segment Outlook: Which Categories Are Growing Fastest?

The liver disease diagnostics market covered in this report is segmented –

1) By Diagnosis Technique: Laboratory Tests, Imaging, Biopsy, Other Diagnosis Techniques

2) By Disease: Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Fibrosis, Cirrhosis, Hepatocellular Carcinoma, Other Diseases

3) By End Users: Hospitals, Laboratories, Other End Users

Subsegments:

1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel), Enzyme Tests (ALT, AST, ALP), Serological Tests

2) By Imaging: Ultrasound Imaging, CT Scans, MRI, Elastography (FibroScan)

3) By Biopsy: Liver Biopsy (Needle Biopsy), Fine Needle Aspiration Biopsy, Laparoscopic Biopsy

4) By Other Diagnosis Techniques: Biomarker Testing, Fibrosis Scoring Systems

#Liver Disease Diagnostics Market Growth Trends: What’s Shaping The Future Outlook?

Major companies operating in the liver disease diagnostics market are focusing on developing innovative solutions, such as non-invasive tools for liver assessment, to develop more accurate and efficient diagnostic methods. A non-invasive tool for liver assessment refers to diagnostic methods that evaluate liver conditions using techniques like elastography or blood tests, avoiding the need for invasive procedures like biopsies. For instance, in September 2024, City Imaging & Clinical, an India-based diagnostic center, launched FibroScan, a non-invasive diagnostic tool for liver assessment, aimed at early detection of liver diseases such as non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). This advanced technology allows for rapid and accurate measurements of liver stiffness and fat content without the need for invasive procedures like biopsies. The procedure is quick, typically lasting 5 to 15 minutes, involving the placement of a probe on the skin over the liver. The probe emits sound waves, which measure liver tissue stiffness, helping assess fibrosis or scarring.

Liver Disease Diagnostics Market Leading Companies And Competitive Benchmarking

Major companies operating in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Fujifilm Holdings Corporation, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, bioMérieux SA, Echosens SA, Hologic Inc., Canon Medical Systems Corporation, GE HealthCare Technologies Inc., Mindray Bio-Medical Electronics Co. Ltd., Samsung Medison Co. Ltd., Bruker Corporation, Sysmex Corporation, DiaSorin S.p.A., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., HEPQuant LLC, Aiforia Technologies Plc

View The Full Liver Disease Diagnostics Market Report:

https://thebusinessresearchcompany.com/report/liver-disease-diagnostics-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Liver Disease Diagnostics Market Geographic Landscape: Which Region Leads Industry Growth?

North America was the largest region in the liver disease diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver disease diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model